Methyl 2-(3,4,5-trimethoxyphenyl)acetate

C12H16O5

MOMETASONE FUROATE USP (PROCESS I)

SAFETY DEVICE P, SAFETY DEVICE PB

EVEROLIMUS PREMIX 2%

GOSERELIN ACETATE

2-(3,5-Dichlorophenyl)-4,4-dimethyl-5-methylidene-4,5-dihydro-1,3-oxazole

C12H11Cl2NO

3,5-Dichloro-N-(1,1-dimethyl-2-oxopropyl)benzamide

C12H13Cl2NO2

17-(Acetyloxy)-6-chloropregna-4,6-diene-3,20-dione

3,4-Dimethylphenylacetonitrile

C10H11N

3,4-Dichlorobenzoyl Chloride

(3R,4S)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)-1-phenylazetidin-2-one

3,5-Dibromo-4-hydroxybenzamide

C7H5Br2NO2

1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-trichloro-, mixt. with 1,3-dichloro-1,3,5-triazine-2,4,6(1H,3H,5H)-trione potassium salt (1:1)

C6Cl5KN6O6

6-(Tert-butylamino)-1,3,5-triazine-2,4-diol

C7H12N4O2

2-(1,2,3,4-Tetrahydroisoquinolin-1-ylmethyl)-isoindole-1,3-dione

C18H16N2O2

Allyl 2,2,3,3,4,4,5,5-octafluoropentyl ether

C8H8F8O

tert-Butyl (2,6-Dioxopiperidin-3-yl)carbamate

1-(2,4-Dihydroxyphenyl)hexan-1-one

(6Z,9Z,12Z)-Octadecatrienoic Acid Ethyl Ester

2,5-Dimethyl-4-nitroaniline

C8H10N2O2

5-Sulfamoyl-1H-1,2,4-triazole-3-carboxylic acid

C3H4N4O4S

N-(2,6-difluorophenyl)-1H-1,2,4-triazole-5-sulfonamide

C8H6F2N4O2S

6-methyl-5,6-dihydro-3H-imidazo[2,1-c][1,2,4]dithiazole-3-thione

C5H6N2S3

2-Chloro-4,6-dimethoxy-1,3,5-triazine

8-(2,6-Diethyl-4-methylphenyl)-1,2,4,5-tetrahydropyrazolo[1,2-d][1,4,5]oxadiazepine-7,9-dione

C18H24N2O3

2,2-Dichlorobenzilic acid, 98+%

C14H10Cl2O3

2,5-Dihydroxyquinoline

9,12-Tetradecadien-1-ol, 1-acetate, (9E,12Z)-

C16H28O2

7-Fluoroindole-1H-2,3-dione

2-methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine

5,6-Dimethoxy-1,3-benzodioxole

C9H10O4

3,3'-Sulfonyldipropiononitrile